THE PHARMACOLOGY OF ANTITHROMBOTIC AND ANTIPLATELET AGENTS
作者： Majed Abu-Hajir , Anthony J. Mazzeo
DOI: 10.1016/S0889-8537(05)70132-2
关键词:
摘要: Recently, there has been a large expansion in the number of agents available to treat and prevent thromboembolic disease. The introduction low molecular weight heparins (LMWHs) already revolutionized way we manage some these conditions. availability newer antiplatelet alternate anticoagulation treatment increased complexity this area but will result better patient care. This article help anesthesiologist become knowledgeable with understand relevant pharmacology issues myriad patients on such therapies perioperative critical care settings.
elsevier.com
sci-hub.se 参考文章(98)
James J. Ferguson, Robin Fox, Meeting highlights. The 69th Scientific Sessions of the American Heart Association in New Orleans, La, November 10-13, 1996. Circulation. ,vol. 95, pp. 761- ,(1997) , 10.1161/01.CIR.95.4.761
B Boneu, G Destelle, , Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thrombosis and Haemostasis. ,vol. 76, pp. 939- 943 ,(1996) , 10.1055/S-0038-1650689
Barry S Coller, Keaven Anderson, Harlan F Weisman, New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thrombosis and Haemostasis. ,vol. 74, pp. 302- 308 ,(1995) , 10.1055/S-0038-1642694
Theodore E Warkentin, Beng H Chong, Andreas Greinacher, None, Heparin-induced thrombocytopenia: towards consensus. Thrombosis and Haemostasis. ,vol. 79, pp. 1- 7 ,(1998) , 10.1055/S-0037-1614206
Edward Young, Philip Wells, Scott Holloway, Jeffrey Weitz, Jack Hirsh, Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thrombosis and Haemostasis. ,vol. 71, pp. 300- 304 ,(1994) , 10.1055/S-0038-1642434
Bernd Pötzsch, Katharina Madlener, Christoph Seelig, Christian F Riess, Andreas Greinacher, Gert Müller-Berghaus, Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time. Thrombosis and Haemostasis. ,vol. 77, pp. 920- 925 ,(1997) , 10.1055/S-0038-1656078
Thomas C. Gasser, In Vitro Studies Fortschritte der Urologie und Nephrologie. pp. 12- 12 ,(1992) , 10.1007/978-3-642-85422-4_3
Denis Clement, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events(CAPRIE). The Lancet. ,vol. 348, pp. 1329- 1339 ,(1996)
H N Magnani, Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172) Thrombosis and Haemostasis. ,vol. 70, pp. 554- 561 ,(1993) , 10.1055/S-0038-1649626
International Stroke Trial Collaborative Group, None, The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke The Lancet. ,vol. 349, pp. 1569- 1581 ,(1997)